These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7393204)

  • 1. Electrophoretic analysis of 3H-pargyline-labeled monoamine oxidases A and B from human and rat cells.
    Costa MR; Breakefield XO
    Mol Pharmacol; 1980 Mar; 17(2):199-205. PubMed ID: 7393204
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophoretic characterization of monoamine oxidase by [3H]pargyline binding in rat hepatoma cells with A and B activity.
    Costa MR; Breakefield XO
    Mol Pharmacol; 1979 Jul; 16(1):242-9. PubMed ID: 481420
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of ubiquitin-dependent regulation of the monoamine oxidase sensitivity to proteolysis and specific inhibition by pargyline].
    Buneeva OA; Medvedeva MV; Medvedev AE
    Biomed Khim; 2008; 54(6):720-6. PubMed ID: 19205432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the structures of monoamine oxidases A and B in rat clonal cell lines.
    Cawthon RM; Breakefield XO
    Biochem Pharmacol; 1983 Feb; 32(3):441-8. PubMed ID: 6847697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Monoamine oxidase defect in essential arterial hypertension: 'a single dose pargyline test'.
    Anselmi R; Buffoni F; Curradi C; Del Bianco PL; Sicuteri F
    Br J Pharmacol; 1974 Nov; 52(3):460P. PubMed ID: 4458871
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine oxidase A and monoamine oxidase B activities are catalyzed by different proteins.
    Smith D; Filipowicz C; McCauley R
    Biochim Biophys Acta; 1985 Sep; 831(1):1-7. PubMed ID: 3899177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ethanol consumption on the sensitivity of rat brain monoamine oxidases to the inhibition by pargyline in vivo and in vitro.
    Panova NG; Axenova LN; Medvedev AE
    Neurobiology (Bp); 2000; 8(3-4):225-30. PubMed ID: 11225512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the structure of A and B forms of human monoamine oxidase.
    Cawthon RM; Pintar JE; Haseltine FP; Breakefield XO
    J Neurochem; 1981 Aug; 37(2):363-72. PubMed ID: 7264664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat monoamine oxidase B expressed in Escherichia coli has a covalently-bound FAD.
    Hirashiki I; Ogata F; Ito A
    Biochem Mol Biol Int; 1995 Sep; 37(1):39-44. PubMed ID: 8653086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type B monoamine oxidase activity in human brain malignant tumors.
    Marcozzi G; Befani O; Mondovì B
    Cancer Biochem Biophys; 1998 Oct; 16(3):287-94. PubMed ID: 10072212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fate of the monoamine oxidase inhibitor pargyline in cultured hepatocytes.
    Mayne AM; Evans PJ
    Biochem Pharmacol; 1987 Jul; 36(14):2289-95. PubMed ID: 3606642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of antisera prepared against pure bovine MAO-B.
    Pintar JE; Levitt P; Salach JI; Weyler W; Rosenberg MB; Breakefield XO
    Brain Res; 1983 Oct; 276(1):127-39. PubMed ID: 6626992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of human blood platelet monoamine oxidase.
    Szutowicz A; Orsulak PJ; Kobes RD
    Biochem Med Metab Biol; 1986 Aug; 36(1):1-7. PubMed ID: 3741695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular weight differences between human platelet and placental monoamine oxidase.
    Brown GK; Powell JF; Craig IW
    Biochem Pharmacol; 1980 Oct; 29(19):2595-603. PubMed ID: 7426066
    [No Abstract]   [Full Text] [Related]  

  • 15. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of monoamine oxidase in mouse neuroblastoma N1E-115 cells.
    Donnelly CH; Richelson E; Murphy DL
    Biochem Pharmacol; 1976 Jul; 25(14):1639-43. PubMed ID: 942463
    [No Abstract]   [Full Text] [Related]  

  • 17. Tyramine and monoamine oxidase inhibitors as modulators of the mitochondrial membrane permeability transition.
    Marcocci L; De Marchi U; Salvi M; Milella ZG; Nocera S; Agostinelli E; Mondovi B; Toninello A
    J Membr Biol; 2002 Jul; 188(1):23-31. PubMed ID: 12172644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
    Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C
    Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone selectively increases monoamine oxidase type A in human skin fibroblasts.
    Edelstein SB; Breakefield XO
    Biochem Biophys Res Commun; 1981 Feb; 98(3):836-43. PubMed ID: 7225122
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
    Palaska E; Aydin F; Uçar G; Erol D
    Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.